Inaliti ye-Brolucizumab-dbll

Umxholo

• Ngaphambi kokufumana inaliti ye-brolucizumab-dbll,
• Ezinye iziphumo ezivela kwi-brolucizumab-dbll injection ingaba yingozi. Ukuba unazo naziphi na kwezi mpawu, biza ugqirha ngokukhawuleza okanye ufumane unyango olungxamisekileyo:

Inaliti ye-Brolucizumab-dbll isetyenziselwa ukunyanga ukubola okuhambelana nobudala obumanzi (i-AMD; isifo esiqhubekayo seliso elibangela ukulahleka kwamandla okubona ngokuthe ngqo kwaye sinokwenza kube nzima ngakumbi ukufunda, ukuqhuba, okanye ukwenza eminye imisebenzi yemihla ngemihla) . I-Brolucizumab-dbll ikwiklasi yamayeza abizwa ngokuba yi-vascular endothelial growth factor A (VEGF-A) antagonists. Isebenza ngokumisa ukukhula okungaqhelekanga kwemithambo yegazi kunye nokuvuza kwiliso (ii) ezinokubangela ukulahleka kombono.

I-Brolucizumab-dbll iza njengesisombululo (ulwelo) ukuze ifakwe kwiliso ngugqirha. Ihlala inikwa kwiofisi kagqirha kube kanye emva kweentsuku ezingama-25 ukuya kuma-31 kwiidosi zokuqala ezi-3, emva koko kube kanye kwiiveki ezi-8 ukuya kwezi-12.

Ngaphambi kokuba ufumane inaliti ye-brolucizumab-dbll, ugqirha wakho uya kulicoceka iliso lakho ukuthintela usulelo kunye nokubamba ilihlo lakho ukunciphisa ukungonwabi ngexesha lenaliti. Unokuziva uxinzelelo kwiliso lakho xa iyeza lifakwa. Emva kwenaliti yakho, ugqirha wakho kuya kufuneka ahlolisise amehlo akho phambi kokuba uphume eofisini.

I-Brolucizumab-dbll ilawula i-AMD emanzi, kodwa ayiyinyangi. Ugqirha wakho uyakukujonga ngononophelo ukuze ubone ukuba isebenza njani i-brolucizumab-dbll. Thetha nogqirha wakho malunga nokuba kufuneka uqhubeke ixesha elingakanani nonyango nge-brolucizumab-dbll.

Buza usokhemesti okanye ugqirha wakho ngekopi yolwazi lomenzi wesigulana.

Eli yeza linokumiselwa ezinye izinto; buza ugqirha wakho okanye usokhemesti ngolwazi oluthe kratya.

Ngaphambi kokufumana inaliti ye-brolucizumab-dbll,

• xelela ugqirha wakho kunye nosokhemesti ukuba ngaba uxabisa i-brolucizumab-dbll, nawaphi na amanye amayeza, okanye naziphi na izithako kwi-brolucizumab-dbll injection. Buza usokhemesti wakho uluhlu lwezithako.
• xelela ugqirha wakho kunye nosokhemesti ukuba loluphi olunye amayeza amiselweyo kunye nalawo angabhalwanga, iivithamini, izongezo zesondlo, kunye nemveliso yamayeza owathathayo okanye oceba ukuyithatha.
• xelela ugqirha wakho ukuba unentsholongwane okanye ujikeleze iliso. Ugqirha wakho uya kukuxelela ukuba akufuneki ufumane inaliti ye-brolucizumab-dbll.
• xelela ugqirha wakho ukuba unayo nayiphi na imeko yonyango.
• xelela ugqirha wakho ukuba ukhulelwe okanye ucwangcise ukukhulelwa. Akufanele ukhulelwe ngexesha lonyango lwakho ngenaliti ye-brolucizumab-dbll kunye nenyanga e-1 emva kwedosi yakho yokugqibela. Ukuba ukhulelwa ngelixa ufumana inaliti ye-brolucizumab-dbll, tsalela ugqirha wakho.
• xelela ugqirha wakho ukuba uncelisa. Musa ukuncancisa ibele ngelixa ufumana inaliti ye-brolucizumab-dbll kunye nenyanga e-1 emva kwedosi yakho yokugqibela.
• Kuya kufuneka uyazi ukuba inaliti ye-brolucizumab-dbll inokubangela iingxaki kwimbono kungekudala emva kokuba ufumane inaliti. Musa ukuqhuba imoto okanye usebenzise oomatshini de umbono wakho ubuyele esiqhelweni.

Ngaphandle kokuba ugqirha wakho akuxelele ngenye indlela, qhubeka nokutya okuqhelekileyo.

Ukuba uphoswa idinga lokufumana inaliti ye-brolucizumab-dbll, tsalela ugqirha ngokukhawuleza.

Ezinye iziphumo ezivela kwi-brolucizumab-dbll injection ingaba yingozi. Ukuba unazo naziphi na kwezi mpawu, biza ugqirha ngokukhawuleza okanye ufumane unyango olungxamisekileyo:

• intlungu yamehlo, ubomvu, okanye uvakalelo ekukhanyeni
• utshintsho kumbono
• ukubona '' iisheyibhile '' okanye amachaphaza amancinci
• ukopha ngaphakathi okanye ngakujikeleze iliso
• ukudumba kweliso okanye ijwabu leso
• irhashalala, urticaria, ukurhawuzelela, okanye bomvu

I-Brolucizumab-dbll inokubangela ezinye iziphumo ebezingalindelekanga. Biza ugqirha wakho ukuba unayo nayiphi na ingxaki engaqhelekanga ngelixa ufumana eliyeza.

Ukuba uhlangabezana neziphumo ebezingalindelekanga ezimandundu, wena okanye ugqirha wakho ungathumela ingxelo kwiNkqubo yoKutya kunye nezoLawulo (i-FDA) yeMedWatch yeNkqubo yokuNgxelo ngezeMeko eziGwenxa kwi-Intanethi (http://www.fda.gov/Safety/MedWatch) okanye ngomnxeba ( 1-800-332-1088).

Gcina lonke ixesha lokudibana nogqirha wakho.

Buza usokhemesti wakho nayiphi na imibuzo onayo malunga nenaliti ye-brolucizumab-dbll.

Kubalulekile ukuba ugcine uluhlu olubhaliweyo lwawo onke amayeza owasebenzisayo amayeza owasebenzisayo, kunye nezinye iimveliso ezinjengeevithamini, iiminerali, okanye ezinye izongezo zokutya. Kuya kufuneka uze nolu luhlu qho xa undwendwela ugqirha okanye ungeniswe esibhedlele. Kukwabalulekile ulwazi ukuba uphathe nawe xa kukho imeko kaxakeka.

• Beovu^®